Skip to content
AnalystLens

Kimberly-Clark 8-K Report, Corporate Update (Dec 4, 2025)

Reports
Other Events·Exhibits & Filings
Filing Date
Filed December 4, 2025
Period End
December 4, 2025
Security
KMB
In the record · 2016–202610-K1110-Q328-K111

KMB filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 111 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Sep ’18Sep ’18
  2. Change in control8-K · Sep ’20Sep ’20
  3. Leadership change8-K · Sep ’22Sep ’22
  4. Deal closed8-K · Nov ’26Nov ’26

01—Abstract

Summary

Summary of the 8-K filed December 4, 2025. Cited figures are marked; the original filing is the authoritative source.

Kimberly-Clark Corporation filed this Form 8-K on December 4, 2025 to recast financial information from its 2024 Form 10-K (filed February 13, 2025) to present its International Family Care and Professional ("IFP") Business as discontinued operations.

The recast is driven by the pending IFP Transaction with Suzano S.A., under which a joint venture comprising substantially all of the IFP Business will be formed. Suzano will acquire a 51% interest for a purchase price of approximately $1.7 billiona, subject to closing adjustments, and Kimberly-Clark will retain a 49% equity interest. The transaction is expected to close in mid-2026, subject to consultation requirements, customary closing conditions and regulatory approvals.

On a continuing-operations basis, the recast shows 2024 net sales of $16.81 billionb, down 2.0% from $17.15 billion in 2023, with organic sales growth of 3.9%. Operating profit rose 40.0% to $2.70 billion, while adjusted operating profit increased 7.3% to $2.73 billion. Diluted earnings per share from continuing operations were $6.41, and adjusted earnings per share were $6.16, up 8.6%.

Income from discontinued operations was $386 millionc in 2024, and total 2024 net income attributable to Kimberly-Clark was $2.55 billion. The filing states that it does not amend or restate the 2024 Form 10-K beyond the discontinued-operations presentation and should be read alongside later SEC filings. The company also reports a 2024 Transformation Initiative with total expected pre-tax costs of approximately $1.5 billion and expected gross productivity savings of $3.0 billion, to be completed by the end of 2026.

02—Key points

Key Highlights

  1. IFP Business reclassified as discontinued operations: the Suzano joint venture covers substantially all of the former IFP segment, with Suzano acquiring 51% for about $1.7 billion and Kimberly-Clark retaining 49%.
  2. Expected closing in mid-2026, subject to consultation requirements, customary closing conditions and required regulatory approvals.
  3. 2024 continuing-operations net sales were $16.81 billion, down 2.0%, with organic sales growth of 3.9%.
  4. 2024 operating profit increased 40.0% to $2.70 billion, including a $565 million gain on the sale of the PPE business and $456 million of 2024 Transformation Initiative charges.
  5. Adjusted EPS from continuing operations was $6.16, up 8.6%; diluted GAAP EPS from continuing operations was $6.41.
  6. Income from discontinued operations was $386 million in 2024, up 26.6%, and total net income attributable to Kimberly-Clark was $2.55 billion.
  7. The 2024 Transformation Initiative is expected to cost about $1.5 billion pre-tax, with $3.0 billion in expected gross productivity savings, and is due for completion by the end of 2026.

03—Questions

Frequently Asked Questions

  1. Why is Kimberly-Clark recasting its 2024 financial statements?

    The company determined that the planned joint venture with Suzano, which will include substantially all of the IFP Business, represents a strategic shift with a major effect on its operations and financial results. Under ASC 205, the IFP Business is therefore reported as discontinued operations for all periods presented.

  2. What will Kimberly-Clark receive and retain in the IFP Transaction?

    Suzano and its subsidiaries will acquire a 51% interest in the joint venture for a purchase price of approximately $1.7 billion, subject to closing adjustments. Kimberly-Clark will retain a 49% equity interest in the joint venture.

  3. When is the IFP Transaction expected to close?

    The filing states the transaction is expected to close in mid-2026, following satisfaction of consultation requirements and customary closing conditions, including required regulatory approvals.

  4. Does this 8-K change the 2024 Form 10-K results?

    The filing says it is not an amendment or restatement of the 2024 Form 10-K. It revises only the portions needed to reflect the IFP Business as discontinued operations, and it should be read with the 2024 Form 10-K and later SEC filings.

  5. How did continuing operations perform in 2024 after the recast?

    Net sales were $16.81 billion, down 2.0%, mainly due to currency impacts and divestitures, partially offset by organic growth of 3.9%. Operating profit rose 40.0% to $2.70 billion, and adjusted operating profit rose 7.3% to $2.73 billion.

04—Continue

← View all 8-K filings